The company has filed two separate families of patent applications and owns several artificial intelligence and machine learning trade secret applications. Patents are beginning to become granted and transition from pending status. The first family of patents filed with the USPTO and WIPO were filed in year 2022. The first machine learning application is detection of many types of matter including but not limited to allergens, fungus, bacteria, viruses, pollutants, contaminates, tissue, stool, urine and blood samples, and blood and biological germs. The self directed system is fully automated with AI agents, drones and robots all working together to detect samples from the air, the surface, and in bodies of water. The system can be operated manually or by automation.
The second family of patent applications are based on self teaching systems that perform physical procedures and applications in the veterinarian, mortuary, and testing practices . These specific industries train the system for autonomous physical medical procedures and applications for performing future human patient medical applications. The company also maintains trade secrets that compliment the patent application technology. These patent applications were filed in 2026 and are based on specifically veterinarian, mortuary, and testing practices that along with the first family of detection applications will compliment many self teaching applications in the testing for medical industries.
Patents 2026 DeTection Inc. patent applications.
Kuwait GRANTED May 2026
South Africa GRANTED March 2026
International and Domestic Patent Pending Applications
2022. USPTO - 18/141,374 ---- PCT/US23/20501
2026 USPTO - 19/532,226 ----- PCT/US26/14456
Trade Secrets also complement the AI technology developed